Safety and efficacy results from Transcend NHL 001, a multicenter phase 1 study of lisocabtagene maraleucel (liso-cel) In relapsed/refractory large B-cell lymphoma Meeting Abstract


Authors: Abramson, J.; Palomba, M. L.; Gordon, L.; Lunning, M.; Wang, M.; Arnason, J.; Mehta, A.; Purev, E.; Maloney, D.; Andreadis, C.; Sehgal, A.; Solomon, S.; Ghosh, N.; Albertson, T.; Garcia, J.; Kostic, A.; Li, D.; Kim, Y.; Siddiqi, T.
Abstract Title: Safety and efficacy results from Transcend NHL 001, a multicenter phase 1 study of lisocabtagene maraleucel (liso-cel) In relapsed/refractory large B-cell lymphoma
Meeting Title: 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)
Journal Title: Bone Marrow Transplantation
Volume: 55
Issue: Suppl. 1
Meeting Dates: 2020 Aug 29-Sept 1
Meeting Location: Virtual
ISSN: 0268-3369
Publisher: Nature Publishing Group  
Date Published: 2020-12-11
Start Page: 43
End Page: 44
Language: English
ACCESSION: WOS:000600556200034
PROVIDER: Clarivate Analytics Web of Science
PROVIDER: wos
PMCID: PMC7729707
PUBMED: 33311610
DOI: 10.1038/s41409-020-01119-3
Notes: Meeting Abstract: O033 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Maria Lia Palomba
    415 Palomba